Clinical identification of colorectal cancer patients benefiting from adjuvant uracil–tegafur (UFT): a randomized controlled trial

摘要

Purpose A randomized controlled trial was conducted to determine whether pathologic necrosis in response to preoperative treatment with uracil–tegafur(UFT) could be used to identify patients with colorectal cancer most likely to benefit from postoperative adjuvant therapy with the drug.